Generics 9

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ethinylestradiol manufacturers

9 products found

Filters

Filters

Filters , active

Country of origin : Argentina

Clear all

9 products found

ethinylestradiol + gestodene

Tablets, film coated 0.02 mg + 0.075 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
COFEPRIS, INVIMA
Manufacturer #2261

The company researches to develop and provide top-quality products and technological development to improve health and quality of life. The company has been committed for more than 100 years and they are constantly evolving with the ever-changing market and staying in forefront of modern pharmacopeia.

Manufacturer usually replies in 6 days

ethinylestradiol + levonorgestrel

Tablets, film coated (0,02 mg + 0,1 mg), (0,030 mg + 0,15 mg)

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
COFEPRIS, INVIMA
Manufacturer #2261

The company researches to develop and provide top-quality products and technological development to improve health and quality of life. The company has been committed for more than 100 years and they are constantly evolving with the ever-changing market and staying in forefront of modern pharmacopeia.

Manufacturer usually replies in 6 days

norgestimate + ethinylestradiol

Tablets 180 mcg + 35 mcg, 215 mcg + 35 mcg, 250 mcg + 35 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17881
Quality, price, innovative molecules as well as the established validity of the active ingredients selected by the doctors due to their effectiveness and reliability, are key factors that enable the company to place its products in the hands of more than 1.5 million patients every month. It is dedicated to the development of pharmaceuticals for psychiatry, cardiology, diabetes, dentistry, gynecology, and oncology, among others.

Manufacturer usually replies in 5 days

levonorgestrel + ethinylestradiol

Tablets, film coated 0.10 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17881
Quality, price, innovative molecules as well as the established validity of the active ingredients selected by the doctors due to their effectiveness and reliability, are key factors that enable the company to place its products in the hands of more than 1.5 million patients every month. It is dedicated to the development of pharmaceuticals for psychiatry, cardiology, diabetes, dentistry, gynecology, and oncology, among others.

Manufacturer usually replies in 5 days

drospirenone + ethinylestradiol

Tablets, film coated (3mg + 0.03mg) , (3mg + 0.02mg)

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
COFEPRIS, INVIMA
Manufacturer #2261

The company researches to develop and provide top-quality products and technological development to improve health and quality of life. The company has been committed for more than 100 years and they are constantly evolving with the ever-changing market and staying in forefront of modern pharmacopeia.

Manufacturer usually replies in 6 days

drospirenone + ethinylestradiol

Tablets, film coated 3 mg + 0.03 mg, 3 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16576
The company has formed in the 1980s for producing manufacturing. They have a laboratory dedicated to research that allows them to develop products that successfully pass the most demanding quality controls at the same level as the most important industries in the world. The optimization of costs in the production processes is transferred to its treatments, allowing it to be deployed in the national market with more than competitive prices, perhaps the lowest in each segment.

Manufacturer usually replies in 60 days

levonorgestrel + ethinylestradiol

Tablets, film coated 0.15 mg + 0.03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16576
The company has formed in the 1980s for producing manufacturing. They have a laboratory dedicated to research that allows them to develop products that successfully pass the most demanding quality controls at the same level as the most important industries in the world. The optimization of costs in the production processes is transferred to its treatments, allowing it to be deployed in the national market with more than competitive prices, perhaps the lowest in each segment.

Manufacturer usually replies in 60 days

levonorgestrel + ethinylestradiol

Tablets, film coated 0.10 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16576
The company has formed in the 1980s for producing manufacturing. They have a laboratory dedicated to research that allows them to develop products that successfully pass the most demanding quality controls at the same level as the most important industries in the world. The optimization of costs in the production processes is transferred to its treatments, allowing it to be deployed in the national market with more than competitive prices, perhaps the lowest in each segment.

Manufacturer usually replies in 60 days

gestodene + ethinylestradiol

Tablets, film coated 0.075 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16576
The company has formed in the 1980s for producing manufacturing. They have a laboratory dedicated to research that allows them to develop products that successfully pass the most demanding quality controls at the same level as the most important industries in the world. The optimization of costs in the production processes is transferred to its treatments, allowing it to be deployed in the national market with more than competitive prices, perhaps the lowest in each segment.

Manufacturer usually replies in 60 days

Ethinylestradiol Uses

Ethinylestradiol is an estrogen medication that widely used in birth control pills in combination with Progestins. In the past, Ethinylestradiol was earlier prescribed to treat various indications such as menopausal symptoms, gynecological disorders, and certain hormone-sensitive cancers. Ethinylestradiol is agonist of the estrogen receptors, the biological target of estrogens like estradiol. It is a synthetic derivative of estradiol, a natural estrogen but differs from it in various ways. Compared to estradiol, Ethinylestradiol has greatly improved bioavailability when taken by mouth, in addition to being more resistant to metabolism. It also shows relatively better efficacy in certain parts of the body like the liver and uterus. These differences make Ethinylestradiol more favorable for use in birth control pills than estradiol. However, high usage can Increase the risk of blood clots and certain other rare adverse side effects.
Ethinylestradiol was the first orally active synthetic estrogen and was described in 1938 by Hans Herloff Inhoffen and Walter Hohlweg of Schering AG in Berlin. Schering got the first approval from the FDA in 1943. It is marketed under the brand name Estinyl. However, it only started being used as birth control pills later in the 1960s. Today, Ethinylestradiol is the exclusive estrogen used for this purpose, making it one of if not the most widely used estrogens. The FDA withdrew approval of Estinyl effective in 2004 at the request of Schering, which had discontinued marketing it. However, the given the obvious societal benefits of the medicine, It is manufactured and sold under several brand names by global and local manufacturers and labelers.

Forms and Dosage

Ethinylestradiol was previously available by itself under the brand name Estinyl in the form of 0.02, 0.05, and 0.5 mg (20, 50, and 500 µg) tablets. It is usually taken by mouth but is also used as a patch and vaginal ring. Ethinylestradiol is available in combination with a progestin as a transdermal contraceptive patch and as a contraceptive vaginal ring. In addition, there is a single preparation containing very low doses of Ethinylestradiol plus a progestin in an oral tablet that remains in use for menopausal hormone therapy.

The cost of Ethinylestradiol

For bulk industrial usage, the powder form is sold commercially at about USD 500. However, one of the commonly sold brands sells for about USD 100 for monthly supply of 30 tablets. In developing world, the price of imported powder is can vary between USD 15-30 due to domestic manufacturers.

How does Ethinylestradiol work?

Ethinylestradiol is a synthetic estrogenic compound. Use of estrogens have a number of effects on the body including reduced bone density. Combined oral contraceptives suppress ovulation by thickening the cervical mucus to prevent sperm from traveling, and preventing changes in the endometrium required in the implantation of a fertilized egg.

Finding Ethinylestradiol Manufacturers and Ethinylestradiol Suppliers

One of the fastest and easiest ways to find Ethinylestradiol manufacturers and Ethinylestradiol suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals.
Usually, finding trusted manufacturers and supplies of specific drugs like Ethinylestradiol can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier.
All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Ethinylestradiol to work with. You can fine-tune your search results using various filters too, letting you search for Ethinylestradiol from specific countries.